New iPad HD could have essential feature for medical professionals.
USMLE Step 2 CK DejaReview on the iPhone, from McGraw-Hill, is a useful tool for review of medical concepts, but not necessarily for test preparation.
ACLS Review app teaches advanced cardiac life support algorithms based on the 2010 American Heart Association guidelines using question & answers and sample ECG strips
The 7″ BlackBerry Playbook seems like the ideal size for in-hospital use. In this in depth review, we look over its excellent hardware design and sleek operating system. But could its lack of medical apps be a a deal breaker for many physicians ?
The medical app industry is a big business, but the apps are no longer the product – the physicians, nurses, and other healthcare providers who use them are. In the first part of this series, we examined some of the financial forces driving the medical app industry. Our focus then was Epocrates, the veritable founder […]
UCLA publishes a study on WANDA, a system to remotely monitor CHF patient symptoms. While the study shows modest benefits, its promise is substantial.
A review of the iPhone USMLE Step 1 Déjà Review app, a relatively affordable way to prepare for the knowledge – but not the application – component of the USMLE Step 1.
South Africa is rolling out new projects aimed to improve access and lessen the burden on the health system using mHealth technology. Similar to telephone interpretation services available in many US hospitals, this cell phone-based medical interpretation service provides interpreters trained in 32 different South African languages for medical interviews and patient communication.
AT&T’s pilot program and its implications for mobile health care and cloud computing
For residents and medical students, this medical app could provide utility by helping to master the physical exam in an innovative fashion.
Medical apps are a big business, but not because of the apps. In this two-part series, we look at how the physicians who use these apps became the product.
Pfizer’s mobile phone based clinical trial and its implications for pharma, drug trials, and mHealth